Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Blood glucose monitoring system is a technique of testing the concentration of glucose in the blood which particularly help in diabetic management. Regular monitoring of blood glucose can help to analyse the effect of food, exercise, medication and illness on the blood sugar level. Blood glucose meters measure glucose in the blood capillary. Invasive glucose monitoring method is the most common method used for monitoring blood glucose level. It involves pricking of hands or fingers to monitor glucose level. Non-invasive glucose monitoring method is the most recently advanced method for glucose monitoring which is being studied and further researches are carried out.
The blood glucose monitoring system markets has a developing potential owing to the continuous technological advancement in the monitoring devices. The major factors driving the blood glucose monitoring system market are the increasing population under the risk of diabetes, rising prevalence of diabetes and increase in adoption of continuous sugar surveillance systems. However, the prominent factor restraining the growth of the global blood glucose monitoring system market is the excessive cost associated with the diagnosis of diabetes, patent expiry issue and inadequate reimbursement related to the application of CGM systems.
Global blood glucose monitoring system market report is segmented into, product type, application, patient care setting and geography. Blood Glucose Monitoring System Market by Product Type Based on product type, the global blood glucose monitoring system market is categorised into self-monitoring blood glucose systems and continuous glucose monitoring systems. The self-monitoring blood glucose system is further sub-segmented into blood glucose meters, testing strips and lancets & lancing devices. Continuous glucose monitoring system is sub segmented into Sensors, transmitters and receivers. The continuous glucose monitoring system accounted for largest market share in 2017. The high growth in the continuous glucose monitoring system segment can be primarily attributed to the rising adoption of minimally invasive procedures.
Based on application, the global blood glucose monitoring system market is segmented into type-1 diabetes, type-2 diabetes and gestational diabetes. Among these segments Type-2 diabetes segment is expected to account for largest share in the global blood glucose monitoring system market. The largest share of this segment can be primarily attributed to Increasing incidences of type-2 diabetes and increasing product launches by medical device manufacturers to enhance patient comfort.
By patient care setting the blood glucose monitoring market is bifurcated into hospitals & clinics and self/home Care. The self/home care setting segment is expected to command the largest share of blood glucose monitoring system market in 2017. Growing diabetic population, increasing awareness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home primarily attributed to the ring adaptation of self/ homecare settings.
By geography blood glucose monitoring system market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Middle East & Africa. North America is expected to be the fastest-growing region during the prediction period. Factors such as rising prevalence of diabetes in the US and Canada is fuelling the growth of the blood glucose monitoring system market in North America.
Some of the key participants in the blood glucose monitoring system market are F.Hoffman-la Roche (Switzerland), Abbott Laboratories (US), LifeScan (Johnson & Johnson)(US), Ascensia Diabetes Care (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US) and Nova Biomedical (US), etc. F.Hoffman-la Roche is one of the leading company in the blood glucose monitoring system market as it offers an extensive range of glucometers and lancets and has a presence in North America, Europe and Asia pacific.
Diabetes is one of the biggest challenges faced by the millions of people and is responsible for the cause of blindness, heart disease, stroke, obesity and renal failures. Glucose is produced from the food we eat and is one of the main sources of energy in human body. Diabetes affects body’s ability to produce insulin, which is a hormone that is needed to process blood glucose in our body. Blood glucose monitoring system assist the patient suffering from diabetes to constantly monitor the blood glucose level and proper management of diabetes. Regular monitoring of blood glucose can help to analyse the effect of food, exercise, medication and illness on the blood sugar level. The major factors driving the blood glucose monitoring system market are the increasing population under the risk of diabetes, rising prevalence of diabetes and increase in adoption of continuous sugar surveillance systems. Based on product type, the global blood glucose monitoring system market is categorised into self-monitoring blood glucose systems and continuous glucose monitoring systems. The self-monitoring blood glucose system is further sub-segmented into blood glucose meters, testing strips and lancets & lancing devices. Continuous glucose monitoring system is sub segmented into Sensors, transmitters and receivers. Based on application, the global blood glucose monitoring system market is segmented into type-1 diabetes, type-2 diabetes and gestational diabetes. Furthermore, by patient care setting the blood glucose monitoring market is bifurcated into hospitals & clinics and self/home Care. By geography blood glucose monitoring system market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Middle East & Africa. North America is expected to be the fastest-growing region during the prediction period. Factors such as rising prevalence of diabetes in the US and Canada is fuelling the growth of the blood glucose monitoring system market in North America. Some of the key participants in the blood glucose monitoring system market are F.Hoffman-la Roche (Switzerland), Abbott Laboratories (US), LifeScan (Johnson & Johnson)(US), Ascensia Diabetes Care (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US) and Nova Biomedical (US), etc.
Why to buy this report:
